ABVC BioPharma, Inc. (ECOC) Net income 2017–2025
ABVC BioPharma, Inc. (ECOC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$7.9MFY2025 · since FY2017: -$4.2M → -$7.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.9M | -61.3% |
| FY2024 | -$4.9M | +37.0% |
| FY2023 | -$7.8M | +52.6% |
| FY2022 | -$16.4M | -27.9% |
| FY2021 | -$12.8M | -21.2% |
| FY2020 | -$10.6M | -169.3% |
| FY2019 | -$3.9M | +35.1% |
| FY2018 | -$6.1M | -42.9% |
| FY2017 | -$4.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice